RWLK - ReWalk Robotics Ltd.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.2425
-0.0590 (-19.57%)
At close: 4:00PM EST

0.2430 0.00 (0.21%)
Pre-Market: 9:11AM EST

Stock chart is not supported by your current browser
Previous Close0.3015
Open0.2415
Bid0.2424 x 3100
Ask0.2450 x 4000
Day's Range0.2350 - 0.2570
52 Week Range0.1610 - 1.3500
Volume54,496
Avg. Volume6,531,375
Market Cap17.725M
Beta (3Y Monthly)2.47
PE Ratio (TTM)N/A
EPS (TTM)-0.5890
Earnings DateMar 6, 2019 - Mar 11, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.75
Trade prices are not sourced from all markets
  • GlobeNewswireyesterday

    ReWalk Robotics Announces Pricing of $4.37 Million Public Offering of Ordinary Shares

    ReWalk Robotics Ltd. (RWLK) (“ReWalk” or the “Company”) today announced the pricing of a public offering of 19,000,000 ordinary shares, offered at a price to the public of $0.23 per share, for gross proceeds of approximately $4.37 million, before deducting placement agent fees and other estimated offering expenses payable by ReWalk. The offering is expected to close on or about February 25, 2018, subject to customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The offering is being conducted as a “best efforts” offering and the placement agent is not obligated to purchase any securities.

  • GlobeNewswire2 days ago

    ReWalk Robotics Announces Proposed Public Offering of Ordinary Shares

    ReWalk Robotics Ltd. (RWLK) (“ReWalk” or the “Company”) today announced that it intends to offer and sell, subject to market and other conditions, its ordinary shares in a public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The offering is being conducted as a “best efforts” offering and the placement agent is not obligated to purchase any securities.

  • ReWalk Announces 510k FDA Submission for ReStore™ Exo-Suit for Stroke Rehabilitation
    PR Newswire3 days ago

    ReWalk Announces 510k FDA Submission for ReStore™ Exo-Suit for Stroke Rehabilitation

    MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Feb. 19, 2019 /PRNewswire/ -- ReWalk Robotics, Ltd. (RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced the submission of its 510k application to the U.S. Food and Drug Administration (FDA) for the ReStore™ exo-suit for gait training during stroke rehabilitation. Strokes are a major cause of serious long-term disability, with over 795,000 people suffering a stroke each year in the U.S. alone. The soft, garment-like design allows variability of movement in combination with first-of-its-kind active ankle assistance that adaptively synchronizes with the patient's natural gait, to facilitate functional gait training activities.

  • ReWalk Announces Cigna as First Private U.S. Insurer to Adopt National Policy Change for Coverage of Personal Exoskeleton Devices
    PR Newswire9 days ago

    ReWalk Announces Cigna as First Private U.S. Insurer to Adopt National Policy Change for Coverage of Personal Exoskeleton Devices

    MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Feb. 13, 2019 /PRNewswire/ -- ReWalk Robotics, Ltd. (RWLK) ("ReWalk" or the "Company"), disclosed today that Cigna Corporation, a leading global health service company, has revised its policy regarding coverage of exoskeleton medical devices for persons with spinal cord injury (SCI). Cigna, which previously had a non-coverage policy, will now review submissions from beneficiaries on a case-by-case basis to consider providing coverage based on medical criteria. This policy revision is the first of its kind by a major private insurer for individuals eligible to use exoskeleton devices.

  • Thomson Reuters StreetEvents10 days ago

    Edited Transcript of RWLK earnings conference call or presentation 8-Feb-19 1:30pm GMT

    Q4 2018 Rewalk Robotics Ltd Earnings Call

  • Associated Press14 days ago

    ReWalk: 4Q Earnings Snapshot

    The Yokneam Ilit, Israel-based company said it had a loss of 10 cents per share. The maker of wearable robotic exoskeletons that help paralyzed patients walk posted revenue of $1.6 million in the period. ...

  • GlobeNewswire14 days ago

    ReWalk Robotics Reports Fourth Quarter 2018 Financial Results

    — 2018 total revenue of $6.5 million and $1.6 million during the fourth quarter of 2018 —— Preparing for 2019 commercial launch of ReStore for stroke patients — YOKNEAM ILIT,.

  • Have Insiders Been Buying ReWalk Robotics Ltd. (NASDAQ:RWLK) Shares?
    Simply Wall St.16 days ago

    Have Insiders Been Buying ReWalk Robotics Ltd. (NASDAQ:RWLK) Shares?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! We've lost count of how many times Read More...

  • GlobeNewswire17 days ago

    ReWalk Robotics to Report Fourth Quarter and Year-End 2018 Financial Results on February 8, 2019

    MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Feb. 05, 2019 -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its.

  • ACCESSWIRE28 days ago

    Watch These 4 Healthcare Stocks Set the Pace on Friday (1/25/19)

    Companies in the healthcare industry have recognized that, as medical experts discover more diseases and ailments, this creates an opportunity to invest in products/services to improve the quality of life for patients. Premier Health Group (OTC:PHGRF) (CSE:PHGI), vTv Therapeutics Inc (VTVT), Canopy Growth Corp (CGC) (WEED.TO), and Rewalk Robotics Ltd (RWLK) represent four healthcare companies determined to invest in the betterment of healthcare. Premier Health Group (OTC:PHGRF) (CSE:PHGI) is a company focused on developing nuanced approaches that combine human skill-based expertise with up and coming technologies for the healthcare industry to create optimal care solutions for their patients.

  • ACCESSWIRElast month

    Best Bottom Bouncing Opportunities

    HENDERSON, NV / ACCESSWIRE / January 17, 2019 / Below are some incredible opportunities in the market today. Gopher Protocol Inc. (GOPH) , is an absolutely fascinating company that was trading has a 52-week ...

  • GlobeNewswirelast month

    ReWalk Announces Preliminary Fiscal Year 2018 Revenue

    ReWalk Robotics Ltd. (RWLK) (“ReWalk” or the “Company”) today announced preliminary, unaudited revenue for the fiscal year ended December 31, 2018. On a preliminary basis, based on the information currently available, for the fiscal year ended December 31, 2018, the Company expects that total revenue for the year will be approximately $6.5 million. With our clinical study accrual now completed, we plan to finalize our ReStore submission to the U.S Food and Drug Administration shortly,” said Larry Jasinski, Chief Executive Officer of ReWalk.

  • Our Take On ReWalk Robotics Ltd.’s (NASDAQ:RWLK) CEO Salary
    Simply Wall St.2 months ago

    Our Take On ReWalk Robotics Ltd.’s (NASDAQ:RWLK) CEO Salary

    Larry Jasinski has been the CEO of ReWalk Robotics Ltd. (NASDAQ:RWLK) since 2012. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of Read More...

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of RWLK earnings conference call or presentation 8-Nov-18 9:30pm GMT

    Q3 2018 Rewalk Robotics Ltd Earnings Call

  • ACCESSWIRE2 months ago

    ReWalk Robotics Is Moving Forward with New Funding, Analysts Review and Company Guidance

    NEW YORK, NY / ACCESSWIRE / December 12, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on ReWalk Robotics, Ltd. (RWLK), a company that develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke. ReWalk recently announced a new funding program and will receive aggregate gross proceeds of approximately $12.1 million from the offering. ReWalk intends to use the net proceeds from the offering for sales, marketing and reimbursement expenses related to market development activities and broadening third-party payor coverage, research and development costs related to developing its lightweight ''soft suit'' exoskeleton technology for various lower limb disabilities, including stroke and other indications affecting the ability to walk, and the repayment of certain outstanding indebtedness.

  • Huawei's CFO arrested after allegedly breaking Iran sanctions
    Yahoo Finance3 months ago

    Huawei's CFO arrested after allegedly breaking Iran sanctions

    Yahoo Finance's LIVE market coverage and analysis of what you need to watch in the stock market begins each day at 9:00 a.m. ET.

  • United Spinal Association Issues Recommendation for Insurers to Consider Powered Exoskeleton Devices Medically Necessary for Paralyzed Individuals
    PR Newswire3 months ago

    United Spinal Association Issues Recommendation for Insurers to Consider Powered Exoskeleton Devices Medically Necessary for Paralyzed Individuals

    MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Nov. 15, 2018 /PRNewswire/ -- ReWalk Robotics, Ltd. (RWLK) ("ReWalk" or the "Company") applauds United Spinal Association's recommendation, dated November 9, 2018, that health insurance providers consider the use of powered exoskeleton devices as medically necessary for eligible individuals with spinal cord injuries (SCI) in both the institutional and home settings who meet the applicable Food and Drug Administration (FDA) indications for use. According to United Spinal Association, exoskeletons have the potential to enable more than 40% of the SCI population to resume ambulation, which can lead to a healthier and improved quality of life, and the benefits of increased physical activity translate into improvements in health outcomes and decreased utilization of high healthcare costs.

  • ReWalk Announces Placement of 500th Exoskeleton System
    PR Newswire3 months ago

    ReWalk Announces Placement of 500th Exoskeleton System

    MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Nov. 9, 2018 /PRNewswire/ -- ReWalk Robotics Ltd. (RWLK) ("ReWalk" or the "Company") announced today that the company has placed its 500th robotic exoskeleton medical device. The majority of these devices are personal systems used by individuals with spinal cord injury in their homes and communities, while others are located in rehabilitation centers to evaluate and train potential new device owners. To continue its growth, the Company is focused on expanding insurance coverage of exoskeletons for all persons with spinal cord injury and has helped develop national coverage policies with payers in several countries, including Germany, Italy and the U.S. Department of Veterans Affairs in the U.S.

  • ReWalk Robotics (RWLK) Reports Q3 Loss, Misses Revenue Estimates
    Zacks3 months ago

    ReWalk Robotics (RWLK) Reports Q3 Loss, Misses Revenue Estimates

    ReWalk (RWLK) delivered earnings and revenue surprises of 13.33% and -23.73%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press3 months ago

    ReWalk: 3Q Earnings Snapshot

    On a per-share basis, the Yokneam Ilit, Israel-based company said it had a loss of 13 cents. The maker of wearable robotic exoskeletons that help paralyzed patients walk posted revenue of $1.6 million ...